Canagliflozin Tablets

Canagliflozin Tablets
Product Description

Meets the RLD EU, US InvoKana, Ready for tech transfer, Dossier readiness Q2 2027

Read more Show less

Srs Life Sciences Pte. Ltd.

  • Country/Region:
    Singapore
  • On CPHI since:
    2016
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Primary activities
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Details
    Reduce the risk of stroke, heart attack, or death in certain people who have type 2 diabetes
  • Selling Points
    Product Features; Product Performance
  • Model
    CRO, CDMO, Technology Transfer
More specifications Fewer specifications

Srs Life Sciences Pte. Ltd.

  • Country/Region:
    Singapore
  • On CPHI since:
    2016
  • Certificates:
    1
  • Employees:
    100 - 249
Company types
CMO/CDMO
Primary activities
Pharmaceutical Company (generic finished products)
View company profile

More Products from Srs Life Sciences Pte. Ltd. (2)

  • Lacosamide ER Capsule

    Product Lacosamide ER Capsule

    RLD : Motpply XR US
    Tech Transfer Readiness- Q2 2027
  • Cariprazine Capsules

    Product Cariprazine Capsules

    Under development, The RLD used is Vraylar, Tech transfer readiness Q4 2026, Dossier readiness Q3 2027

Srs Life Sciences Pte. Ltd. resources (1)